LifeSci Acquisition Corp. (LSACU), announced the pricing of their upsized $60 million SPAC IPO this evening and the units are expected to begin trading tomorrow, Friday, March 6th, under the symbol Nasdaq: LSACU.
LifeSci Acquisition Corp. will be focusing on companies that have their primary operations located in North America in the healthcare industry and will be led by Andrew McDonald, Ph.D., as Chairman, Chief Executive Officer and Board Member. He will be joined by Michael Rice, as Chief Operating Officer and Board Member, and David Dobkin, as Chief Financial Officer and Board Member.
Total SPAC deal count for 2020 year-to-date is now 12 with $3.6 billion in gross proceeds raised. The offering is anticipated to close on Tuesday, March 10, 2020.
Congratulations to all.
Chardan acted as sole book-running manager for the offering. Loeb & Loeb LLP and Kirkland & Ellis LLP were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC acted as auditor.